163 related articles for article (PubMed ID: 32413099)
1. Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome.
Reynaud-Dulaurier R; Benegiamo G; Marrocco E; Al-Tannir R; Surace EM; Auwerx J; Decressac M
Brain; 2020 Jun; 143(6):1686-1696. PubMed ID: 32413099
[TBL] [Abstract][Full Text] [Related]
2. AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.
Di Meo I; Marchet S; Lamperti C; Zeviani M; Viscomi C
Gene Ther; 2017 Oct; 24(10):661-667. PubMed ID: 28753212
[TBL] [Abstract][Full Text] [Related]
3. Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice.
Corrà S; Cerutti R; Balmaceda V; Viscomi C; Zeviani M
Brain; 2022 Oct; 145(10):3405-3414. PubMed ID: 36270002
[TBL] [Abstract][Full Text] [Related]
4. The Blood-Brain Barrier Is Unaffected in the
Reynaud-Dulaurier R; Clément R; Yjjou S; Cresson C; Saoudi Y; Faideau M; Decressac M
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732047
[TBL] [Abstract][Full Text] [Related]
5. Targeting NAD
Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
[TBL] [Abstract][Full Text] [Related]
6. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia ameliorates brain hyperoxia and NAD
Grange RMH; Sharma R; Shah H; Reinstadler B; Goldberger O; Cooper MK; Nakagawa A; Miyazaki Y; Hindle AG; Batten AJ; Wojtkiewicz GR; Schleifer G; Bagchi A; Marutani E; Malhotra R; Bloch DB; Ichinose F; Mootha VK; Zapol WM
Mol Genet Metab; 2021 May; 133(1):83-93. PubMed ID: 33752971
[TBL] [Abstract][Full Text] [Related]
8. Fatal breathing dysfunction in a mouse model of Leigh syndrome.
Quintana A; Zanella S; Koch H; Kruse SE; Lee D; Ramirez JM; Palmiter RD
J Clin Invest; 2012 Jul; 122(7):2359-68. PubMed ID: 22653057
[TBL] [Abstract][Full Text] [Related]
9. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
[TBL] [Abstract][Full Text] [Related]
10. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
11. Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome.
Aguilar K; Comes G; Canal C; Quintana A; Sanz E; Hidalgo J
Glia; 2022 Nov; 70(11):2032-2044. PubMed ID: 35770802
[TBL] [Abstract][Full Text] [Related]
12. Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome.
Piroli GG; Manuel AM; Clapper AC; Walla MD; Baatz JE; Palmiter RD; Quintana A; Frizzell N
Mol Cell Proteomics; 2016 Feb; 15(2):445-61. PubMed ID: 26450614
[TBL] [Abstract][Full Text] [Related]
13. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.
Morabito G; Giannelli SG; Ordazzo G; Bido S; Castoldi V; Indrigo M; Cabassi T; Cattaneo S; Luoni M; Cancellieri C; Sessa A; Bacigaluppi M; Taverna S; Leocani L; Lanciego JL; Broccoli V
Mol Ther; 2017 Dec; 25(12):2727-2742. PubMed ID: 28882452
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene.
Leong DW; Komen JC; Hewitt CA; Arnaud E; McKenzie M; Phipson B; Bahlo M; Laskowski A; Kinkel SA; Davey GM; Heath WR; Voss AK; Zahedi RP; Pitt JJ; Chrast R; Sickmann A; Ryan MT; Smyth GK; Thorburn DR; Scott HS
J Biol Chem; 2012 Jun; 287(24):20652-63. PubMed ID: 22535952
[TBL] [Abstract][Full Text] [Related]
15. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
Elife; 2023 Feb; 12():. PubMed ID: 36799301
[TBL] [Abstract][Full Text] [Related]
16. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.
Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M
Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of AAV-Slc25a46 mitigates mitochondrial neuropathy in Slc25a46-/- mice.
Yang L; Slone J; Li Z; Lou X; Hu YC; Queme LF; Jankowski MP; Huang T
Hum Mol Genet; 2020 Mar; 29(4):649-661. PubMed ID: 31943007
[TBL] [Abstract][Full Text] [Related]
18. Peripheral macrophages drive CNS disease in the Ndufs4(-/-) model of Leigh syndrome.
Hanaford AR; Khanna A; Truong V; James K; Chen Y; Mulholland M; Kayser B; Liao RW; Sedensky M; Morgan P; Baertsch NA; Kalia V; Sarkar S; Johnson SC
Brain Pathol; 2023 Nov; 33(6):e13192. PubMed ID: 37552802
[TBL] [Abstract][Full Text] [Related]
19. A Single Intravenous Injection of AAV-PHP.B-
Silva-Pinheiro P; Cerutti R; Luna-Sanchez M; Zeviani M; Viscomi C
Mol Ther Methods Clin Dev; 2020 Jun; 17():1071-1078. PubMed ID: 32478122
[TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
